537 related articles for article (PubMed ID: 28189533)
1. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
[TBL] [Abstract][Full Text] [Related]
2. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
[TBL] [Abstract][Full Text] [Related]
3. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.
Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A
J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912
[TBL] [Abstract][Full Text] [Related]
4. Key role of pancreatic stellate cells in pancreatic cancer.
Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
Cancer Lett; 2016 Oct; 381(1):194-200. PubMed ID: 26571462
[TBL] [Abstract][Full Text] [Related]
5. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.
Nielsen MF; Mortensen MB; Detlefsen S
World J Gastroenterol; 2016 Mar; 22(9):2678-700. PubMed ID: 26973408
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.
Rucki AA; Zheng L
World J Gastroenterol; 2014 Mar; 20(9):2237-46. PubMed ID: 24605023
[TBL] [Abstract][Full Text] [Related]
7. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.
Li X; Ma Q; Xu Q; Duan W; Lei J; Wu E
Curr Pharm Des; 2012; 18(17):2404-15. PubMed ID: 22372501
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer and its stroma: a conspiracy theory.
Xu Z; Pothula SP; Wilson JS; Apte MV
World J Gastroenterol; 2014 Aug; 20(32):11216-29. PubMed ID: 25170206
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes.
Kadaba R; Birke H; Wang J; Hooper S; Andl CD; Di Maggio F; Soylu E; Ghallab M; Bor D; Froeling FE; Bhattacharya S; Rustgi AK; Sahai E; Chelala C; Sasieni P; Kocher HM
J Pathol; 2013 May; 230(1):107-17. PubMed ID: 23359139
[TBL] [Abstract][Full Text] [Related]
10. Blocking CTGF-Mediated Tumor-Stroma Interplay in Pancreatic Cancer.
Shen YW; Zhou YD; Luan X; Zhang WD
Trends Mol Med; 2020 Dec; 26(12):1064-1067. PubMed ID: 32928643
[TBL] [Abstract][Full Text] [Related]
11. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.
Apte MV; Wilson JS
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():69-74. PubMed ID: 22320920
[TBL] [Abstract][Full Text] [Related]
12. Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.
Mutgan AC; Besikcioglu HE; Wang S; Friess H; Ceyhan GO; Demir IE
Mol Cancer; 2018 Feb; 17(1):66. PubMed ID: 29475434
[TBL] [Abstract][Full Text] [Related]
13. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.
Thomas D; Radhakrishnan P
Mol Cancer; 2019 Jan; 18(1):14. PubMed ID: 30665410
[TBL] [Abstract][Full Text] [Related]
14. Biology and clinical applications of pancreatic cancer stem cells.
Abel EV; Simeone DM
Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133
[TBL] [Abstract][Full Text] [Related]
15. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
[TBL] [Abstract][Full Text] [Related]
16. [The impact of desmoplasia and pancreatic stellate cells on pancreatic cancer].
Nielsen MF; Mortensen MB; Detlefsen S
Ugeskr Laeger; 2015 Aug; 177(34):. PubMed ID: 26320589
[TBL] [Abstract][Full Text] [Related]
17. The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets.
Farran B; Nagaraju GP
Cytokine Growth Factor Rev; 2019 Aug; 48():11-23. PubMed ID: 31331827
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation.
Coleman SJ; Watt J; Arumugam P; Solaini L; Carapuca E; Ghallab M; Grose RP; Kocher HM
World J Gastroenterol; 2014 Jul; 20(26):8471-81. PubMed ID: 25024603
[TBL] [Abstract][Full Text] [Related]
19. Cytokine network: new targeted therapy for pancreatic cancer.
Matsuo Y; Takeyama H; Guha S
Curr Pharm Des; 2012; 18(17):2416-9. PubMed ID: 22372505
[TBL] [Abstract][Full Text] [Related]
20. Breaking the stromal barrier in pancreatic cancer: Advances and challenges.
Chakkera M; Foote JB; Farran B; Nagaraju GP
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189065. PubMed ID: 38160899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
